Atlas Trials

Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome

Clinical trial NCT00570128 · COMPLETED

Trial details

NCT number
NCT00570128
Sponsor
Eisai Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Down Syndrome
Start date
2007-11-16
Primary completion
2008-09-05
Enrollment
129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.